Expert Group Reviews Evidence for Diabetes Devices
Original Article: https://www.medtechdive.com/news/medcac-medicare-advisory-panel-diabetes-device-evidence/716869
What are the Benefits of New Technologies for Diabetes?
In the United States, the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) recently assessed the effectiveness of advanced diabetes devices. These technologies include continuous glucose monitors and insulin pumps, which are designed to help people living with diabetes successfully manage blood glucose levels to prevent the serious complications associated with diabetes and to prevent dangerous swings in glucose levels. The committee’s aim was to determine whether these devices provide health benefits and improve outcomes compared to traditional methods of diabetes management such as insulin pens and finger stick monitoring of blood glucose.
Concerns Over Insufficient Data
One of the main concerns highlighted during the review was the lack of extensive data demonstrating the long-term benefits of these devices. While short-term studies show promising results in controlling blood glucose levels, there is still uncertainty about their impact on overall health outcomes over extended periods. Experts emphasized the need for more evidence to support the widespread adoption of these technologies under Medicare coverage.
Future Directions and Policy Implications
The committee’s findings could influence Medicare policies regarding coverage for advanced diabetes devices for older Americans. If the evidence supports their effectiveness in improving health outcomes and quality of life for people with diabetes, it may lead to broader coverage under Medicare. However, until more conclusive data is available, the committee remains cautious about recommending universal coverage without clear evidence of long-term benefits.
